WallStreetZenWallStreetZen

NASDAQ: CLDX
Celldex Therapeutics Inc Stock Ownership - Who owns Celldex Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Celldex Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13341$23.95
$8.17kSell
Freddy A. JimenezSVP GENERAL COUNSEL2025-08-13430$25.42
$10.93kSell
Anthony S. MarucciPRESIDENT CEO2024-11-1111,500$26.82
$308.43kBuy

1 of 1

CLDX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CLDX insiders and whales buy or sell their stock.

CLDX Shareholders

What type of owners hold Celldex Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Thomas S. Paluck11.50%7,632,346$186.61MInsider
Kynam Capital Management LP9.19%6,100,729$149.16MInstitution
Blackrock Inc8.36%5,550,016$135.70MInstitution
Fmr LLC8.19%5,439,118$132.99MInstitution
Wellington Management Group LLP7.88%5,232,326$127.93MInstitution
Vanguard Group Inc5.96%3,957,122$96.75MInstitution
Price T Rowe Associates Inc5.75%3,817,820$93.35MInstitution
Commodore Capital LP5.20%3,450,000$84.35MInstitution
Bellevue Group Ag4.98%3,307,569$80.87MInstitution
Medarex Inc4.46%2,960,848$72.39MInsider

1 of 3

CLDX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CLDX85.11%14.89%Net BuyingNet Selling
VCEL91.49%8.51%Net SellingNet Buying
YDES0.00%3.67%
ARDX42.58%57.42%Net BuyingNet Buying
BCRX84.08%15.92%Net SellingNet Buying
View Top Biotech Stocks

Celldex Therapeutics Stock Ownership FAQ

Who owns Celldex Therapeutics?

Celldex Therapeutics (NASDAQ: CLDX) is owned by 109.48% institutional shareholders, 19.16% Celldex Therapeutics insiders, and 0.00% retail investors. Thomas S. Paluck is the largest individual Celldex Therapeutics shareholder, owning 7.63M shares representing 11.50% of the company. Thomas S. Paluck's Celldex Therapeutics shares are currently valued at $186.61M.

If you're new to stock investing, here's how to buy Celldex Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.